Skip to main content
Equibles

ARGX · Argenx SE · Held by Funds

Track ARGX — free

Use ARGX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ARGX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$958.91 -11.75 (-1.21%) At close · Sep 30
Rebalance outlook locked
Market Cap
$60.40B
Shares
62.56M
Volume · Sep 30 243.7K Avg daily vol (3M) 283.45K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding ARGX

371 fund positions
Fund Balance Value % of Fund Open
EUPAC Fund 1,024,240 $950,259,145 0.67%
New Economy Fund 713,694 $596,641,047 1.16%
Fidelity Growth Company Fund 609,066 $509,173,085 0.52%
Janus Henderson Forty Fund 518,956 $481,471,808 2.02%
Fidelity OTC Portfolio 481,926 $411,478,057 0.95%
iShares Biotechnology ETF 368,177 $341,583,575 3.76%
Janus Henderson Enterprise Fund 309,064 $286,740,307 1.28%
T. Rowe Price Growth Stock Fund, Inc. 225,019 $208,765,878 0.42%
Invesco American Franchise Fund 245,620 $205,335,864 1.12%
T. Rowe Price Large-Cap Growth Fund 211,419 $196,148,206 0.95%
Fidelity Contrafund 210,533 $195,326,201 0.11%
T. Rowe Price New Horizons Fund, Inc. 208,186 $193,148,725 1.31%
Fidelity Puritan Fund 209,689 $175,297,907 0.52%
T. Rowe Price Overseas Stock Fund 188,952 $161,330,997 0.65%
Artisan Mid Cap Fund 169,567 $157,319,176 4.93%
Janus Henderson Global Life Sciences Fund 164,585 $152,697,025 2.63%
VIP Contrafund Portfolio 164,280 $152,414,056 0.50%
Fidelity Advisor Growth Opportunities Fund 181,699 $151,898,547 0.43%
Fidelity Growth Company K6 Fund 171,204 $143,124,832 0.52%
Janus Henderson Contrarian Fund 144,283 $133,861,439 2.44%
Fidelity Advisor New Insights Fund 139,632 $129,546,381 0.46%
Old Westbury Large Cap Strategies Fund 150,330 $128,354,761 0.50%
Bridge Builder Small/Mid Cap Growth Fund 129,194 $119,862,317 1.07%
Select Biotechnology Portfolio 141,444 $118,245,770 2.25%
Fidelity Series Growth Company Fund 139,160 $116,336,368 0.48%
Select Health Care Portfolio 108,000 $90,286,920 1.56%
First Trust NYSE Arca Biotechnology Index Fund 94,913 $88,057,434 3.13%
T. Rowe Price International Stock Fund 102,743 $87,724,028 0.65%
Janus Henderson Overseas Fund 89,503 $83,038,198 1.81%
Capital Group Global Growth Equity ETF 98,382 $82,246,368 0.73%
BlackRock Health Sciences Opportunities Portfolio 88,995 $74,398,930 1.26%
Fidelity Series Opportunistic Insights Fund 78,000 $72,366,060 0.47%
Artisan Global Opportunities Fund 76,920 $71,364,068 4.44%
T. Rowe Price Health Sciences Fund, Inc. 76,622 $71,087,593 0.60%
Global Growth Fund 76,588 $71,056,049 0.66%
VIP Growth Portfolio 76,247 $70,739,679 0.57%
T. Rowe Price All-Cap Opportunities Fund 75,549 $70,092,096 0.48%
Eventide Gilead Fund 75,482 $70,029,935 2.04%
Bridge Builder Large Cap Growth Fund 73,896 $68,558,492 0.23%
Fidelity Advisor Equity Growth Fund 81,500 $68,133,185 0.50%
Invesco Main Street Fund 78,114 $66,695,295 0.58%
Fidelity Advisor Biotechnology Fund 77,200 $65,914,904 3.00%
Fidelity Advisor Health Care Fund 76,500 $65,317,230 2.09%
College Retirement Equities Fund - Total Global Stock Account 69,920 $64,869,678 0.04%
ClearBridge Value Fund 75,000 $64,036,500 1.50%
Fidelity Balanced Fund 75,411 $63,042,842 0.10%
AB LARGE CAP GROWTH FUND INC 67,260 $62,401,810 0.27%
Strategic Advisers Fidelity U.S. Total Stock Fund 72,300 $60,442,077 0.02%
Lord Abbett Growth Leaders Fund 66,050 $56,394,811 0.76%
Artisan International Fund 57,401 $53,254,926 0.79%
Showing 1–50 of 371 positions
Key facts CIK 1697862 CUSIP 04016X101 13F (30d) 11 filings 11 filers Visit website Investor relations